November 21, 2001 |
Financier Carl Icahn renewed his efforts to oust the board of Visx Inc., the biggest maker of lasers used in eye surgery, and proposed for election a five-member slate that includes himself. Icahn and affiliates said in a letter dated Tuesday that they believe his nominees will be better able to "enhance stockholders' value." The letter was submitted with a filing to the Securities and Exchange Commission. "Mr.
May 13, 1999 |
Presiding over the last annual meeting of tobacco and food behemoth RJR Nabisco Holdings Co., Chairman Steven Goldstone said Wednesday that the $8-billion sale of international tobacco operations allowed a split into "two companies that are in really good shape." Goldstone, ending a tumultuous era storied in the movie and book "Barbarians at the Gate," called his experience at the helm "an interesting ride." "All's well that ends well," he said.
March 31, 2000 |
Financier Carl Icahn, who has tried repeatedly to wrest control of Nabisco Group Holdings Corp. in recent years, said Thursday that he plans to buy a $1.3-billion stake in the company and push for its sale. Icahn said he is prepared to offer $13 each for 100 million shares of the company, whose main asset is an 80.5% stake in Nabisco Holdings Corp., maker of Oreo cookies, Ritz crackers and Life Savers candies.
August 31, 2005 |
Carl Icahn's life story is producing the kind of returns that the billionaire has reaped from more than four decades of investing. "King Icahn: The Biography of a Renegade Capitalist" by Mark Stevens first sold for $23 when it was published in 1993. The out-of-stock book is now on sale by various merchants on Internet retailer Amazon.com Inc. for as much as $240. "I should have collected" copies of the book, Icahn said. "It would have been a good investment."
October 26, 2006 |
Billionaire investor Carl Icahn won his two-month campaign to take control of ImClone Systems Inc. on Wednesday, ousting the biotechnology company's interim chief executive and engineering his own election as chairman. Icahn said he would seek a new chief executive with experience to boost sales of the New York-based biotechnology company's only product, the Erbitux cancer drug. ImClone's third-quarter profit rose 85%, beating analyst estimates, although sales of Erbitux were less than expected.
April 11, 2000 |
Carl Icahn said Monday that he reached an agreement with Nabisco Group Holdings Corp. that will allow the financier to see the company's books and solicit partners for his $4.7-billion takeover offer. In return for the confidentiality agreement, Icahn agreed to drop his month-old proxy fight for Nabisco Group's board. Icahn said he hired Industrial Bank of Japan to study an acquisition of the company, whose only asset is an 80.6% stake in cookie and cracker maker Nabisco Holdings Corp.
May 16, 2000 |
Stocks made a surprising advance Monday on the eve of the Federal Reserve's meeting, as some investors may have bet that the central bank is nearing the end of its credit-tightening cycle. But trading volume remained extremely light, indicating most investors remain wary of the Fed's intentions. The Dow Jones industrial average rose 198.41 points, or 1.9%, to close at 10,807.78. The Nasdaq composite, helped by a late surge, rose 78.59 points, or 2.2%, to 3,607.65. Nasdaq plunged 7.
April 4, 2000 |
Nabisco Group Holdings Corp. on Monday again rebuffed a bid by financier Carl Icahn to seize control of the company, but this time Nabisco Group said it would weigh alternative moves--including a sale of the firm. Nabisco Group's sole asset is an 80.5% ownership stake in Nabisco Holdings Corp., the snack maker whose products include Ritz crackers, Oreo cookies and LifeSavers candies. The rest of Nabisco Holding's stock is publicly held.
June 7, 2000 |
Bestfoods on Tuesday agreed to a sweetened buyout offer from Unilever of $20.3 billion, or $73 a share, that would create the world's biggest food maker. The Anglo-Dutch company won over Bestfoods Chairman Charles Shoemate by raising its cash offer a month after he rejected a bid for $66 a share. Shoemate opened merger talks with Campbell Soup Co., Diageo and H.J. Heinz Co., people close to the situation have said.